Schedule 13D ownership disclosure

KALOBIOS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 48344T100

Event date: 2016-08-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
Unavailable

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-141737
Form type
SC 13D/A
Filer
HUMANIGEN, INC
CIK
CIK 1293310
Filed
Aug 29, 2016
Reporting period
Aug 25, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub